Physical inactivity is common during periods of self-isolation, but for patients with rheumatic
diseases, there are crucial benefits to be gained from maintaining an active lifestyle …

Abstract Aims Lipoprotein (a)[Lp (a)] is a causal and independent risk factor for
cardiovascular disease (CVD). People with elevated Lp (a) are often prescribed statins as …

Abstract An Expert Panel convened by the National Lipid Association previously developed
a consensus set of recommendations for the patient-centered management of dyslipidemia …

2016 Chinese guidelines for the management of dyslipidemia in adults Page 1 Journal of
Geriatric Cardiology (2018) 15: 1-29 ©2018 JGC All rights reserved; www.jgc301.com http://www.jgc301.com; …

Patients with rheumatoid arthritis (RA) are at high risk of developing cardiovascular disease
(CVD). Inflammation has a pivotal role in the pathogenesis of CVD. RA is an inflammatory …

Background Lowering LDL cholesterol with statin regimens reduces the risk of myocardial
infarction, ischaemic stroke, and the need for coronary revascularisation in people without …

The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued
an evidence-based set of guidelines on cholesterol management in 2001. Since the …

Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are associated with
skeletal muscle complaints, including clinically important myositis and rhabdomyolysis, mild …

Background Ezetimibe, a cholesterol-absorption inhibitor, reduces levels of low-density
lipoprotein (LDL) cholesterol when added to statin treatment. However, the effect of …

Ezetimibe is a potent inhibitor of cholesterol absorption that has been approved for the
treatment of hypercholesterolemia, but its molecular target has been elusive. Using a …